Baseline Predictors of Response to Radial Pressure Wave Therapy in Knee Osteoarthritis
PRE-RPWT-OA
Baseline Predictors of Six-Month Clinical Response to Radial Pressure Wave Therapy in Patients With Knee Osteoarthritis: Secondary Analysis of a Randomized Double-Blind Clinical Trial.
1 other identifier
observational
62
1 country
1
Brief Summary
This observational study aims to identify baseline factors that predict clinical response at six months in patients with knee osteoarthritis treated with radial pressure wave therapy (rESWT). The study is a secondary analysis of data obtained from a randomized double-blind clinical trial conducted in 2024 at a tertiary care hospital in Mexico. Knee osteoarthritis is a common condition that causes pain, stiffness, and reduced physical function. Radial pressure wave therapy is a non-invasive treatment that has shown benefits in improving symptoms; however, not all patients respond equally. This study will analyze patient characteristics at baseline, such as age, body mass index, pain severity, and functional status, to determine which factors are associated with meaningful improvement in pain and function after treatment. The results may help clinicians better identify which patients are more likely to benefit from this therapy and improve personalized treatment decisions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2025
CompletedFirst Submitted
Initial submission to the registry
April 9, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedApril 15, 2026
April 1, 2026
1 month
April 9, 2026
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Achievement of minimal clinically important difference (MCID) in pain intensity measured by the Numerical Pain Rating Scale (NPRS)
The proportion of patients achieving the minimal clinically important difference (MCID) in pain intensity measured using the Numerical Pain Rating Scale (NPRS), a validated 0 to 10 scale where higher scores indicate greater pain.
6 months after baseline
Secondary Outcomes (3)
Achievement of minimal clinically important difference (MCID) in pain intensity measured by the Numerical Pain Rating Scale (NPRS)
6 months after baseline
Change in WOMAC score over time
Baseline, 2 months, 4 months, and 6 months
Change in pain intensity measured by the Numerical Pain Rating Scale (NPRS) over time
Baseline, 2 months, 4 months, and 6 months
Study Arms (1)
Patients with knee osteoarthritis treated with radial pressure wave therapy
Adult patients with clinically and radiographically diagnosed knee osteoarthritis who participated in a randomized double-blind clinical trial evaluating radial pressure wave therapy (rESWT) in 2024. This cohort includes participants with complete baseline and follow-up data up to six months and is used to identify baseline predictors of clinical response.
Interventions
Radial pressure wave therapy (rESWT) administered according to standardized protocols in the original randomized clinical trial. The therapy involves the application of acoustic waves to the knee joint to reduce pain and improve function.
Eligibility Criteria
Adult patients with clinically and radiographically confirmed knee osteoarthritis who participated in a randomized double-blind clinical trial evaluating radial pressure wave therapy (rESWT) at a tertiary care hospital in Mexico in 2024. Only participants with complete baseline and six-month follow-up data are included in this secondary analysis.
You may qualify if:
- Clinical and radiographic diagnosis of knee osteoarthritis
- Participation in the original randomized double-blind clinical trial evaluating radial pressure wave therapy (rESWT) in 2024
- Availability of complete baseline data
- Availability of follow-up data up to 6 months
You may not qualify if:
- Incomplete baseline or follow-up data
- Withdrawal from the original trial before completion
- Missing outcome measurements required for analysis
- Presence of conditions that could interfere with outcome assessment or data validity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Civil de Guadalajara Fray Antonio Alcalde
Guadalajara, Jalisco, 44280, Mexico
Related Publications (4)
Melese H, Alamer A, Getie K, Nigussie F, Ayhualem S. Extracorporeal shock wave therapy on pain and foot functions in subjects with chronic plantar fasciitis: systematic review of randomized controlled trials. Disabil Rehabil. 2022 Sep;44(18):5007-5014. doi: 10.1080/09638288.2021.1928775. Epub 2021 May 26.
PMID: 34038642RESULTCharles R, Fang L, Zhu R, Wang J. The effectiveness of shockwave therapy on patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis: a systematic review and meta-analysis. Front Immunol. 2023 Aug 16;14:1193835. doi: 10.3389/fimmu.2023.1193835. eCollection 2023.
PMID: 37662911RESULTLi H, Xiong Y, Zhou W, Liu Y, Liu J, Xue H, Hu L, Panayi AC, Mi B, Liu G. Shock-wave therapy improved outcome with plantar fasciitis: a meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg. 2019 Dec;139(12):1763-1770. doi: 10.1007/s00402-019-03262-z. Epub 2019 Aug 21.
PMID: 31435724RESULTVahdatpour B, Sajadieh S, Bateni V, Karami M, Sajjadieh H. Extracorporeal shock wave therapy in patients with plantar fasciitis. A randomized, placebo-controlled trial with ultrasonographic and subjective outcome assessments. J Res Med Sci. 2012 Sep;17(9):834-8.
PMID: 23826009RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Armando Tonatiuh Avila Garcia, MD
Hospital Civil de Guadalajara
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Department of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
April 9, 2026
First Posted
April 15, 2026
Study Start
November 19, 2024
Primary Completion
December 26, 2024
Study Completion
January 20, 2025
Last Updated
April 15, 2026
Record last verified: 2026-04